EDGE MEDICAL-B (02675) saw its share price jump more than 4% during intraday trading on Wednesday, with the stock last up 3.1% at HK$36.64, recording a turnover of HK$6.6361 million.

In terms of news flow, according to the official website of the China Securities Regulatory Commission (CSRC) on September 22, Shenzhen Edge Medical Technology Co., Ltd. formally initiated its listing advisory process on September 21, with CITIC Securities serving as the company's advisory institution.

Previously, EDGE MEDICAL-B announced that it would explore preliminary proposals for issuing RMB shares, launching plans for an initial public offering of ordinary RMB shares and listing on the A-share market (the "Proposed A-Share Listing"). The proposed issuance of RMB shares is subject to and conditional upon, among other things, prevailing market conditions, further approval from the board of directors, approval from the company's shareholders at a general meeting, and clearance from the requisite regulatory authorities.